Reviva Pharmaceuticals Holdings, Inc.
RVPH
$0.53
-$0.01-1.13%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 59.56% | 50.32% | 46.20% | 52.06% | 22.98% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -44.14% | -31.88% | -27.37% | 76.35% | 142.09% |
| Change in Net Operating Assets | -82.05% | 54.58% | 16.60% | -153.65% | 184.74% |
| Cash from Operations | 57.80% | 53.61% | 36.29% | -31.78% | 40.86% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -27.58% | -- | -- |
| Total Debt Repaid | 21.51% | 24.93% | 100.00% | 9.08% | 10.76% |
| Issuance of Common Stock | -- | 4,764.50% | -60.06% | 127.47% | 263.54% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -101.83% | 158,156.16% | -58.55% | 132.16% | 276.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -145.33% | 194.68% | -84.14% | 555.20% | 187.56% |